Ambar Protein Industries sets Sept 30 AGM for shareholder votes
- Ambar Protein Industries schedules 33rd AGM for September 30, 2026
- Shareholders to approve ₹401 crore related-party transactions with Ankur Oil Industries
- Remuneration variations proposed for MD and Whole Time Director
- E-voting window opens September 27 with record date on September 24

*this image is generated using AI for illustrative purposes only.
Ambar Protein Industries Limited has scheduled its 33rd Annual General Meeting for September 30, 2026, at its registered office in Ahmedabad. The company confirmed the record date for voting eligibility as September 24, 2026.
The Ambar Protein Industries Board seeks shareholder consent for transactions totaling ₹401 crore with Ankur Oil Industries, alongside remuneration variations for the Managing Director and Whole Time Director. Shareholders are also reminded to update their KYC details and dematerialize physical securities as per SEBI regulations.
Key Agenda Items
The meeting will address both ordinary and special business items. Shareholders will vote on the adoption of financial statements for the year ended March 31, 2026, and the re-appointment of directors retiring by rotation.
Related-Party Transactions
The most material special business item involves approving related-party transactions under Section 188 of the Companies Act, 2013. The Company proposes to enter into the following arrangements with Ankur Oil Industries:
| Transaction Type | Amount (₹ crore) |
|---|---|
| Sale of goods | 400.00 |
| Leasing/sublease/rent | 1.00 |
| Disposal of machinery | 1.50 |
These transactions involve common partners among the Company’s directors, including Mr. Pradeep C Khetani and Mr. Jayprakash J Vachhani. The Board states these deals are conducted on an arm’s length basis.
Management Remuneration
Shareholders will decide on varying the remuneration of two key executives:
- Mr. Pradeep Chunilal Khetani (Managing Director): His current monthly draw is ₹1,75,000. The proposed variation allows his annual pay to exceed ₹1 crore or 5% of net profits, whichever is higher.
- Mr. Jayprakash J Vachhani (Whole Time Director): Similarly, his remuneration may exceed statutory limits pending shareholder approval.
Additionally, the meeting will approve a commission for Non-Executive Director Mr. Bharatbhai D Patel at 1% of net profits for five years starting October 1, 2026.
Voting and Book Closure Details
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with section 91 of the Companies Act, 2013, the Register of Members and Share Transfer Books will remain closed from Thursday, September 24, 2026 to Wednesday, September 30, 2026 (both days inclusive).
Remote e-voting begins on September 27, 2026, at 9:00 am and ends on September 30, 2026, at 5:00 pm. The cut-off date for e-voting is Wednesday, September 23, 2026.
Annual Report and Compliance Updates
The company has dispatched letters to members who have not registered their email addresses, providing web-links to access the Integrated Annual Report for FY26. The report is available on the company’s website under the investors section.
Shareholders holding physical securities are urged to update their KYC details, including PAN, address, bank account details, and nomination choices, pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37. Failure to update these details may result in payments being made only through electronic mode.
Historical Stock Returns for Ambar Protein Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -11.19% | -18.22% | +31.84% | -34.80% | 0.0% |
How will the ₹401 crore related-party transactions with Ankur Oil Industries impact Ambar Protein's supply chain resilience and profit margins in the upcoming fiscal year?
What are the potential implications for minority shareholders given the proposed remuneration increase allowing the MD's pay to exceed ₹1 crore or 5% of net profits?
Will the disposal of machinery worth ₹1.50 crore signal a strategic shift in Ambar Protein's production capacity or technological modernization efforts?


































